JP2024520797A5 - - Google Patents
Info
- Publication number
- JP2024520797A5 JP2024520797A5 JP2023575790A JP2023575790A JP2024520797A5 JP 2024520797 A5 JP2024520797 A5 JP 2024520797A5 JP 2023575790 A JP2023575790 A JP 2023575790A JP 2023575790 A JP2023575790 A JP 2023575790A JP 2024520797 A5 JP2024520797 A5 JP 2024520797A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2108176.5 | 2021-06-08 | ||
| GBGB2108176.5A GB202108176D0 (en) | 2021-06-08 | 2021-06-08 | Vector |
| GB2207077.5 | 2022-05-14 | ||
| GBGB2207077.5A GB202207077D0 (en) | 2022-05-14 | 2022-05-14 | Vector |
| PCT/GB2022/051437 WO2022258967A1 (en) | 2021-06-08 | 2022-06-08 | Lentiviral vector |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024520797A JP2024520797A (ja) | 2024-05-24 |
| JP2024520797A5 true JP2024520797A5 (https=) | 2025-06-02 |
| JPWO2022258967A5 JPWO2022258967A5 (https=) | 2025-06-02 |
Family
ID=82067426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023575790A Pending JP2024520797A (ja) | 2021-06-08 | 2022-06-08 | レンチウイルスベクター |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250122528A1 (https=) |
| EP (1) | EP4352238A1 (https=) |
| JP (1) | JP2024520797A (https=) |
| KR (1) | KR20240024807A (https=) |
| AU (1) | AU2022289260A1 (https=) |
| BR (1) | BR112023025408A2 (https=) |
| CA (1) | CA3222751A1 (https=) |
| IL (1) | IL308705A (https=) |
| MX (1) | MX2023014228A (https=) |
| WO (1) | WO2022258967A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025076341A1 (en) * | 2023-10-05 | 2025-04-10 | Janssen Biotech, Inc. | Improved methods in lentiviral manufacturing for production of car-t cell drug products |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5834256A (en) | 1993-06-11 | 1998-11-10 | Cell Genesys, Inc. | Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| FR2722506B1 (fr) | 1994-07-13 | 1996-08-14 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucleiques, preparation et utilisations |
| GB0901593D0 (en) | 2009-01-30 | 2009-03-11 | Touchlight Genetics Ltd | Production of closed linear DNA |
| GB201013153D0 (en) | 2010-08-04 | 2010-09-22 | Touchlight Genetics Ltd | Primer for production of closed linear DNA |
| GB201502645D0 (en) | 2015-02-17 | 2015-04-01 | Touchlight Genetics Ltd | Method |
| DK3500682T3 (da) | 2016-08-16 | 2020-08-24 | Touchlight Ip Ltd | Fremstilling af lukket, lineært dna |
| KR20190089988A (ko) * | 2016-12-06 | 2019-07-31 | 블루버드 바이오, 인코포레이티드. | I형 점액다당류증에 대한 유전자 요법 |
-
2022
- 2022-06-08 US US18/567,499 patent/US20250122528A1/en active Pending
- 2022-06-08 AU AU2022289260A patent/AU2022289260A1/en active Pending
- 2022-06-08 CA CA3222751A patent/CA3222751A1/en active Pending
- 2022-06-08 EP EP22730967.1A patent/EP4352238A1/en active Pending
- 2022-06-08 WO PCT/GB2022/051437 patent/WO2022258967A1/en not_active Ceased
- 2022-06-08 KR KR1020237042463A patent/KR20240024807A/ko active Pending
- 2022-06-08 BR BR112023025408A patent/BR112023025408A2/pt unknown
- 2022-06-08 MX MX2023014228A patent/MX2023014228A/es unknown
- 2022-06-08 JP JP2023575790A patent/JP2024520797A/ja active Pending
- 2022-06-08 IL IL308705A patent/IL308705A/en unknown